Invesco Ltd. Personalis, Inc. Transaction History

Invesco Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.27 - $8.76 $46,237 - $123,866	-14,140 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.56 - $14.3 $718 - $1,358	95 Added 0.68%	14,140 $116,000
Q4 2021 Feb 14, 2022	SELL	$12.24 - $21.25 $44,982 - $78,093	-3,675 Reduced 20.74%	14,045 $200,000
Q3 2021 Nov 15, 2021	BUY	$16.69 - $26.05 $32,895 - $51,344	1,971 Added 12.52%	17,720 $340,000
Q2 2021 Aug 17, 2021	BUY	$18.15 - $27.75 $120,207 - $183,788	6,623 Added 72.57%	15,749 $399,000
Q1 2021 May 17, 2021	SELL	$20.71 - $51.02 $9.16 Million - $22.6 Million	-442,143 Reduced 97.98%	9,126 $224,000
Q4 2020 Feb 16, 2021	BUY	$21.84 - $44.0 $5.43 Million - $10.9 Million	248,835 Added 122.92%	451,269 $16.5 Million
Q3 2020 Nov 16, 2020	BUY	$13.63 - $24.12 $2.76 Million - $4.88 Million	202,434 New	202,434 $4.39 Million

30M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $225M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.